Serenici (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Serenici" in Italian language version.

refsWebsite

Global rank Italian rank

13oadoi.org

799^th place

22^nd place

13doi.org

2^nd place

7^th place

12nih.gov

4^th place

9^th place

3worldcat.org

5^th place

26^th place

3unibo.it

4,963^rd place

325^th place

1clinicalneuropsychiatry.org

low place

1web.archive.org

1^st place

clinicalneuropsychiatry.org

PDF Document: http://www.clinicalneuropsychiatry.org/pdf/01_verhoeven.pdf Archiviato il 27 settembre 2018 in Internet Archive. Source: http://www.clinicalneuropsychiatry.org/risultatiRicerca.php# Archiviato il 27 settembre 2018 in Internet Archive.

doi.org

dx.doi.org

Berend Olivier e Jan Mos, Serenics and aggression, in Stress Medicine, vol. 2, n. 3, 1986, pp. 197–209, DOI:10.1002/smi.2460020305, ISSN 0748-8386 (WC · ACNP).
Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others, in Biol. Psychiatry, vol. 68, n. 12, December 2010, pp. 1134–40, DOI:10.1016/j.biopsych.2010.08.003, PMID 20947066.
MDMA enhances emotional empathy and prosocial behavior, in Soc Cogn Affect Neurosci, vol. 9, n. 11, October 2013, pp. 1645–52, DOI:10.1093/scan/nst161, PMID 24097374.
Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects, in J Clin Psychopharmacol, vol. 20, n. 4, August 2000, pp. 455–66, DOI:10.1097/00004714-200008000-00010, PMID 10917407.
Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram, in Neuropsychopharmacology, vol. 33, n. 5, April 2008, pp. 1192–205, DOI:10.1038/sj.npp.1301491, PMID 17609680.
Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration, in Soc Neurosci, vol. 4, n. 4, 2009, pp. 359–66, DOI:10.1080/17470910802649470, PMID 19562632.
Oxytocinergic regulation of endogenous as well as drug-induced mood, in Pharmacol. Biochem. Behav., vol. 119, April 2014, pp. 61–71, DOI:10.1016/j.pbb.2013.07.002, PMID 23872370.
5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis, in Eur. J. Pharmacol., vol. 526, 1–3, December 2005, pp. 125–39, DOI:10.1016/j.ejphar.2005.09.065, PMID 16310183.
Berend Olivier, Serotonin and Aggression, in Annals of the New York Academy of Sciences, vol. 1036, n. 1, 2006, pp. 382–392, DOI:10.1196/annals.1330.022, ISSN 0077-8923 (WC · ACNP), PMID 15817750.
Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior, in Pharmacol. Biochem. Behav., vol. 83, n. 2, February 2006, pp. 169–74, DOI:10.1016/j.pbb.2006.01.001, PMID 16504276.
Antiaggressive activity of central oxytocin in male rats, in Psychopharmacology, vol. 229, n. 4, October 2013, pp. 639–51, DOI:10.1007/s00213-013-3124-7, PMID 23624810.
Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice, in Neurochem. Res., vol. 33, n. 10, October 2008, pp. 1990–2007, DOI:10.1007/s11064-008-9718-5, PMID 18473173.
Karine M. Fabio, Christophe D. Guillon e Shi-Fang Lu, Pharmacokinetics and Metabolism of SRX246: A Potent and Selective Vasopressin 1a Antagonist, in Journal of Pharmaceutical Sciences, vol. 102, n. 6, 2013, pp. 2033–2043, DOI:10.1002/jps.23495, ISSN 0022-3549 (WC · ACNP), PMID 23471831.

nih.gov

ncbi.nlm.nih.gov

Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others, in Biol. Psychiatry, vol. 68, n. 12, December 2010, pp. 1134–40, DOI:10.1016/j.biopsych.2010.08.003, PMID 20947066.
MDMA enhances emotional empathy and prosocial behavior, in Soc Cogn Affect Neurosci, vol. 9, n. 11, October 2013, pp. 1645–52, DOI:10.1093/scan/nst161, PMID 24097374.
Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects, in J Clin Psychopharmacol, vol. 20, n. 4, August 2000, pp. 455–66, DOI:10.1097/00004714-200008000-00010, PMID 10917407.
Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram, in Neuropsychopharmacology, vol. 33, n. 5, April 2008, pp. 1192–205, DOI:10.1038/sj.npp.1301491, PMID 17609680.
Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration, in Soc Neurosci, vol. 4, n. 4, 2009, pp. 359–66, DOI:10.1080/17470910802649470, PMID 19562632.
Oxytocinergic regulation of endogenous as well as drug-induced mood, in Pharmacol. Biochem. Behav., vol. 119, April 2014, pp. 61–71, DOI:10.1016/j.pbb.2013.07.002, PMID 23872370.
5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis, in Eur. J. Pharmacol., vol. 526, 1–3, December 2005, pp. 125–39, DOI:10.1016/j.ejphar.2005.09.065, PMID 16310183.
Berend Olivier, Serotonin and Aggression, in Annals of the New York Academy of Sciences, vol. 1036, n. 1, 2006, pp. 382–392, DOI:10.1196/annals.1330.022, ISSN 0077-8923 (WC · ACNP), PMID 15817750.
Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior, in Pharmacol. Biochem. Behav., vol. 83, n. 2, February 2006, pp. 169–74, DOI:10.1016/j.pbb.2006.01.001, PMID 16504276.
Antiaggressive activity of central oxytocin in male rats, in Psychopharmacology, vol. 229, n. 4, October 2013, pp. 639–51, DOI:10.1007/s00213-013-3124-7, PMID 23624810.
Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice, in Neurochem. Res., vol. 33, n. 10, October 2008, pp. 1990–2007, DOI:10.1007/s11064-008-9718-5, PMID 18473173.
Karine M. Fabio, Christophe D. Guillon e Shi-Fang Lu, Pharmacokinetics and Metabolism of SRX246: A Potent and Selective Vasopressin 1a Antagonist, in Journal of Pharmaceutical Sciences, vol. 102, n. 6, 2013, pp. 2033–2043, DOI:10.1002/jps.23495, ISSN 0022-3549 (WC · ACNP), PMID 23471831.

oadoi.org

Berend Olivier e Jan Mos, Serenics and aggression, in Stress Medicine, vol. 2, n. 3, 1986, pp. 197–209, DOI:10.1002/smi.2460020305, ISSN 0748-8386 (WC · ACNP).
Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others, in Biol. Psychiatry, vol. 68, n. 12, December 2010, pp. 1134–40, DOI:10.1016/j.biopsych.2010.08.003, PMID 20947066.
MDMA enhances emotional empathy and prosocial behavior, in Soc Cogn Affect Neurosci, vol. 9, n. 11, October 2013, pp. 1645–52, DOI:10.1093/scan/nst161, PMID 24097374.
Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects, in J Clin Psychopharmacol, vol. 20, n. 4, August 2000, pp. 455–66, DOI:10.1097/00004714-200008000-00010, PMID 10917407.
Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram, in Neuropsychopharmacology, vol. 33, n. 5, April 2008, pp. 1192–205, DOI:10.1038/sj.npp.1301491, PMID 17609680.
Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration, in Soc Neurosci, vol. 4, n. 4, 2009, pp. 359–66, DOI:10.1080/17470910802649470, PMID 19562632.
Oxytocinergic regulation of endogenous as well as drug-induced mood, in Pharmacol. Biochem. Behav., vol. 119, April 2014, pp. 61–71, DOI:10.1016/j.pbb.2013.07.002, PMID 23872370.
5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis, in Eur. J. Pharmacol., vol. 526, 1–3, December 2005, pp. 125–39, DOI:10.1016/j.ejphar.2005.09.065, PMID 16310183.
Berend Olivier, Serotonin and Aggression, in Annals of the New York Academy of Sciences, vol. 1036, n. 1, 2006, pp. 382–392, DOI:10.1196/annals.1330.022, ISSN 0077-8923 (WC · ACNP), PMID 15817750.
Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior, in Pharmacol. Biochem. Behav., vol. 83, n. 2, February 2006, pp. 169–74, DOI:10.1016/j.pbb.2006.01.001, PMID 16504276.
Antiaggressive activity of central oxytocin in male rats, in Psychopharmacology, vol. 229, n. 4, October 2013, pp. 639–51, DOI:10.1007/s00213-013-3124-7, PMID 23624810.
Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice, in Neurochem. Res., vol. 33, n. 10, October 2008, pp. 1990–2007, DOI:10.1007/s11064-008-9718-5, PMID 18473173.
Karine M. Fabio, Christophe D. Guillon e Shi-Fang Lu, Pharmacokinetics and Metabolism of SRX246: A Potent and Selective Vasopressin 1a Antagonist, in Journal of Pharmaceutical Sciences, vol. 102, n. 6, 2013, pp. 2033–2043, DOI:10.1002/jps.23495, ISSN 0022-3549 (WC · ACNP), PMID 23471831.

unibo.it

acnpsearch.unibo.it

Berend Olivier e Jan Mos, Serenics and aggression, in Stress Medicine, vol. 2, n. 3, 1986, pp. 197–209, DOI:10.1002/smi.2460020305, ISSN 0748-8386 (WC · ACNP).
Berend Olivier, Serotonin and Aggression, in Annals of the New York Academy of Sciences, vol. 1036, n. 1, 2006, pp. 382–392, DOI:10.1196/annals.1330.022, ISSN 0077-8923 (WC · ACNP), PMID 15817750.
Karine M. Fabio, Christophe D. Guillon e Shi-Fang Lu, Pharmacokinetics and Metabolism of SRX246: A Potent and Selective Vasopressin 1a Antagonist, in Journal of Pharmaceutical Sciences, vol. 102, n. 6, 2013, pp. 2033–2043, DOI:10.1002/jps.23495, ISSN 0022-3549 (WC · ACNP), PMID 23471831.

web.archive.org

PDF Document: http://www.clinicalneuropsychiatry.org/pdf/01_verhoeven.pdf Archiviato il 27 settembre 2018 in Internet Archive. Source: http://www.clinicalneuropsychiatry.org/risultatiRicerca.php# Archiviato il 27 settembre 2018 in Internet Archive.

worldcat.org

Berend Olivier e Jan Mos, Serenics and aggression, in Stress Medicine, vol. 2, n. 3, 1986, pp. 197–209, DOI:10.1002/smi.2460020305, ISSN 0748-8386 (WC · ACNP).
Berend Olivier, Serotonin and Aggression, in Annals of the New York Academy of Sciences, vol. 1036, n. 1, 2006, pp. 382–392, DOI:10.1196/annals.1330.022, ISSN 0077-8923 (WC · ACNP), PMID 15817750.
Karine M. Fabio, Christophe D. Guillon e Shi-Fang Lu, Pharmacokinetics and Metabolism of SRX246: A Potent and Selective Vasopressin 1a Antagonist, in Journal of Pharmaceutical Sciences, vol. 102, n. 6, 2013, pp. 2033–2043, DOI:10.1002/jps.23495, ISSN 0022-3549 (WC · ACNP), PMID 23471831.